Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs)

Critical Reviews in Toxicology

Volumn 32, Issue 6, 2002, Pages 521-549

  O'Connor, John C ^a   Cook, Jon C ^b   Marty, M Sue ^c   Davis, Leonard G ^a   Kaplan, A Michael ^a   Carney, Edward W ^c  

^a DUPONT COMPANY   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c DOW CHEMICAL COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; HORMONE; HORMONE DERIVATIVE; XENOBIOTIC AGENT;

ANIMAL MODEL; BIOASSAY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; ENDOCRINE FUNCTION; LAW; REVIEW; SCREENING TEST; STEROIDOGENESIS; VALIDATION PROCESS; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENDOCRINE SYSTEM; FEMALE; HEALTH CARE QUALITY; MALE; METHODOLOGY; RAT; STANDARD; UTERUS;

ANIMALIA;

ANIMALS; BIOLOGICAL ASSAY; ENDOCRINE SYSTEM; FEMALE; MALE; PROGRAM EVALUATION; RATS; RECEPTORS, ESTROGEN; UTERUS; XENOBIOTICS;

EID: 0036445966     PISSN: 10408444     EISSN: None     Source Type: Journal    
DOI: 10.1080/20024091064309     Document Type: Review

References (128)

1. Aguilar, R., Bellido, C., Sanchez-Criado, J. E., and Aguilar, E. (1988). Mechanisms of precocious puberty in male rats by pituitary grafts. J. Reprod. Fertil. 83, 879-883.
2. Arnold, S. F., Robinson, M. K., Notides, A. C., Guillette, L. J., and MacLachlan, J. A. (1996). A yeast estrogen screen for examining the relative exposure of cells to natural and xenoestrogens. Environ. Health Perspect. 104, 544-548.
3. Ashby, J. and Lefevre, P. A. (1997). The weanling male rat as an assay for endocrine disruption: Preliminary observations. Reg. Toxicol. Pharmacol. 26, 330-337.
4. Ashby, J. and Lefevre, P. A. (2000a). The peripubertal male rat assay as an alternative to the Hershberger castrated male rat assay for the detection of anti-androgens, oestrogens, and metabolic modulators. J. Appl. Toxicol. 20, 35-47.
5. Ashby, J. and Lefevre, P. A. (2000b). Preliminary evaluation of the major protocol variables for the Hershberger castrated male rat assay for the detection of androgens, antiandrogens, and metabolic modulators. Reg. Toxicol. Pharmacol. 31, 92-105.
6. Ashby, J., Lefevre, P. A., Odum, J., Harris, C. A., Routledge, E. J., and Sumpter, J. P. (1997). Synergy between synthetic oestrogens? Nature 385, 494.
7. Biegel, L. B., Cook, J. C., O'Connor, J. C., Aschiero, M., Arduengo, A. J., and Slone, T. W. (1995). Subchronic toxicity study in rats with 1-methyl-3-propylimidazole-2-thione (PTI): Effects on the thyroid. Fundam. Appl. Pharmacol. 27, 185-194.
8. Blanchard, E. L., Allan, S. A., and Harling, R. J. (2001). Hershberger assay: Demonstration of dose response and comparison of endpoints using testosterone propinoate. The Toxicologist 60, 223-224.
9. Bogdanffy, M., Daston, G., Faustman, E., Kimmel, C., Kimmel, G., Seed, J., and Vu, V. (2001). Harmonization of cancer and non-cancer risk assessment: Proceedings of a consensus-building workshop. Toxicol. Sci. 61, 18-31.
10. Brodie, A. and Wing, L.-Y. (1987). In vitro and in vivo studies with aromatase inhibitor 4-hydroxyandrostenedione. Steroids 50, 89-103.
11. Brueggemeier, R. W., Gilbert, N. E., Gu, X., O'Reilly, J. M., and Lovely, C. J. (1997). Aromatase inhibition in JAr choriocarcinoma cells by 7α-arylaliphatic androgens. J. Steroid Biochem. Mol. Biol. 61, 73-77.
12. Cameron, J. L. (1991). Metabolic cues for the onset of puberty. Horm. Res. 36, 97-103.
13. Campbell, J. M., and Hutchinson, T. H. (1998). Wildlife and endocrine disrupters: Requirements for hazard identification. Environ. Toxicol. Chem. 17, 127-135.
14. Capen, C. C. (1996). Toxic responses of the endocrine system. In: Casarett and Doull's Toxicology: The Basic Science of Poisons (C. D. Klaassen, Ed., pp. 617-640. McGraw-Hill, New York.
15. Capen, C. C. (1997). Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol. Pathol. 25, 39-48.
16. Carney, E. W., Scortichini, B. S., and Crissman, J. W. (1998). Feed restriction during in utero and neonatal life: Effects on reproductive and developmental endpoints in the CD rat. Toxicologist 42, 102-103.
17. Christian, M. S., Hoberman, A. M., Bachmann, S., and Hellwig, J. (1998). Variability in the uterotrophic response assay (an in vivo estrogenic response assay) in untreated control and positive controls (DES-DP, 2.5 μg/kg, BID) Wistar and Sprague-Dawley rats. Drug Chem. Toxicol. 21 (Suppl. 1), 51-100.
18. Cicero, T. J., Adams, M. L., Giordano, A., Miller, B. T., O'Connor, L., and Nock, B. (1991). Influence of morphine exposure during adolescence on the sexual maturation of male rats and the development of their offspring. J. Pharmacol. Exp. Ther. 256, 1086-1093.
19. Cicero, T. J., Adams, M. L., O'Connor, L., Nock, B., Meyer, E. R., and Wozniak, D. (1990). Influence of chronic alcohol administration on representative indices of puberty and sexual maturation in male rats and the development of their progeny. J. Pharmacol. Exp. Ther. 255, 707-715.
20. Clark, J. H. and Mani, S. K. (1994). Actions of ovarian steroid hormones. In The Physiology of Reproduction (J. D. Neill, ed., pp. 1011-1059. Raven Press, New York.
21. Clark, R. L. (1999). Endpoints of reproductive system development. In: An Evaluation and Interpretation of Reproductive Endpoints for Human Risk Assessment, pp. 27-62. International Life Sciences Institute, Health and Environmental Science Institute, Washington D.C.
22. Collu, R., Letarte, J., Leboeuf, F., and Ducharme, J. R. (1975). Endocrine effects of chronic administration of psychoactive drugs to prepubertal male rats. I. delta9-tetrahydrocannabinol. Life Sci. 16, 533-542.
23. Cook, J. C., Kaplan, A. M., Davis, L. G., and O'Connor, J. C. (1997). Development of a Tier I screening battery for detecting endocrine active compounds (EACs). Regul. Toxicol. Pharmacol. 26, 60-68.
24. Cook, J. C., Mullin, L. S., Frame, S. R., and Biegel, L. B. (1993). Investigation of a mechanism for Leydig cell tumorigenesis by linuron in rats. Toxicol. Appl. Pharmacol. 119, 195-204.
25. Docke, F. (1977). A possible mechanism of the puberty-delaying effect of hippocampal lesions in female rats. Endokrinologie 69, 258-261.
26. Docke, F., Lange, T., and Dorner, G. (1980). Involvement of a cholinergic mechanism in the mediation of hippocampal influences on female sexual maturation and somatic development. Endokrinologie 75, 8-12.
27. Docke, F., Lung, D., and Flother, T. (1983). Effects of rostro-dorsal deafferentiation of the hypothalamus on the onset of puberty in female rats. Exp. Clin. Endocrinol. 81, 245-248.
28. EDSTAC (1998). Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) Final Report, August 1998.
29. Evans, R. (1988). The steroid and thyroid hormone receptor superfamily. Science 240, 889-895.
30. Fauss, J. and Pyerin, W. (1993). Rapid assay of aromatase activity by fast liquid chromatography: Spectroscopic evaluation of metabolite profiles indicate unexpected pitfalls. Anal. Biochem. 210, 421-423.
31. Feldman, D. (1986). Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis. Endocrine Rev. 7, 409-420.
32. Frisch, R. E., Hegsted, D. M., and Yoshinaga, K. (1975). Body weight and food intake at early estrus of rats on a high-fat diet. Proc. Natl. Acad. Sci. USA 72, 4172-4176.
33. Gaido, K. W., Leonard, L. S., Lovell, S., Gould, J. C., Babai, D., Portier, C. J., and McDonnell, D. P. (1997). Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143, 205-212.
34. Glass, A. R., Harrison, R., and Swerdloff, R. S. (1976). Effect of undernutrition and amino acid deficiency on the timing of puberty in rats. Pediat. Res. 10, 951-955.
35. Glass, A. R. and Swerdloff, R. S. (1980). Nutritional influences on sexual maturation in the rat. Fed. Proc. 39, 2360-2364.
36. Goldman, J. M., Laws, S. C., Balchak, S. K., Cooper, R. L., and Kavlock, R. J. (2000). Endocrine-disrupting chemicals: Prepubertal exposures and effects on sexual maturation and thyroid activity in the female rat. A focus on the EDSTAC recommendations. Crit. Rev. Toxivol. 30, 135-196.
37. Gray, L. E., Klinefelter, G., Laskey, W., Ostby, J., and Ewing, L. (1995). Hamster Leydig cells are less sensitive to ethane dimethanesulfonate when compared to rat Leydig cells both in vivo and in vitro. Toxicol. Appl. Pharmacol. 130, 248-256.
38. Gray, L. E., Ostby, J., Ferrell, J., Rehnberg, G., Linder, R., Cooper, R., Goldman, J., Slott, V., and Laskey, J. (1989). A dose-response analysis of methoxychlor-induced alterations of reproductive development and function in the rat. Fundam. Appl. Toxicol. 12, 92-108.
39. Grota, L. J. (1971). Effects of age and experience on plasma testosterone. Neuroendocrinology 8, 136-143.
40. Harling, R. J., Blanchard, E. L., and Allan, S. A. (2001). The uterotrophic assay: Comparison of mature ovariectomized and immature female rats as a model. The Toxicologist 60, 295 (abstract).
41. Hershberger, L. G., Shipley, E. G., and Meyer, R. K. (1953). Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method. Proc. Soc. Exp. Biol. Med. 83, 175-180.
42. Huhtaniemi, I. T., Nevo, N., Amsterdam, A., and Naor, Z. (1986). Effect of postnatal treatment with a gonadotropin-releasing hormone antagonist on sexual maturation of male rats. Biol. Reprod. 35, 501-507.
43. Hutchinson, T. H., Brown, R., Brugger, K. E., Campbell, P. M., Holt, M., Lange, R., McCahon, P., Tattersfield, L. J., and VanEgmond, R. (2000). Ecological risk assessment of endocrine disruptors. Environ. Health Perspect. 108, 1007-1014.
44. Kelce, W. R., Stone, C. R., Laws, S. C., Gray, L. E., Kemppainen, J. A., and Wilson, E. M. (1995). Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature 375, 581-585.
45. Kennedy, G. C., and Mitra, J. (1963). Body weight and food intake as initiating factors for puberty in the rat. J. Physiol. 166, 408-418.
46. Kennedy, R. I., Rawlings, N. C., and Murphy, B. D. (1985). The effects of androgens and gonadotropins on testicular development in the prepubertal rat. Can. J. Comp. Med. 49, 333-336.
47. Klein, K. O., Demers, L. M., Santner, S. J., Baron, J., Cutler, G. B., and Santen, R. J. (1995). Use of ultrasensitive recombinant cell bioassay to measure estrogen levels in women with breast cancer receiving the aromatase inhibitor, Letrozole. J. Clini. Endocrinol. Metabolism 80, 2658-2660.
48. Klinefelter, G. and Kelce, W. R. (1996). Leydig cell responsiveness to hormonal and nonhormonal factors in vivo and in vitro. In: The Leydig Cell (L. D. Russell, Ed., pp. 535-553). Cache River Press, Vienna.
49. Korenbrot, C. C., Huhtaniemi, I. T., and Weiner, R. I. (1977). Preputial separation as an external sign of pubertal development in the male rat. Biol. Reprod. 17, 298-303.
50. Lang, U., Rivest, R. W., Schlaepfer, L. V., Dradtke, J. C., Aubert, M. L., and Sizonenko, P. C. (1984). Diurnal rhythm of melatonin action on sexual maturation. Neuroendocrinology 38, 261-268.
51. Laskey, J. W., Klinefelter, G. R., Kelce, W. R., and Eming, L. L. (1994). Effects of ethane dimethanesulfonate (EDS) on adult and immature rabbit Leydig cells: Comparison with EDS-treated rat Leydig cells. Biol. Reprod. 50, 1151-1160.
52. Laws, S. C., Carey, S. A., Ferrell, J. M., Bodman, G. J., and Cooper, R. L. (2000a). Estrogenic activity of octylphenol, nonylphenol, bisphenol A, and methoxychlor in rats. Toxicol. Sci. 54, 154-167.
53. Laws, S. C., Ferrell, J. M., Stoker, T. E., Schmid, J., and Cooper, R. L. (2000b). The effect of atrazine on female wistar rats: An evaluation of the protocol for assessing pubertal development and thyroid function. Toxicol. Sci. 58, 366-376.
54. Lephart, E. D. and Simpson, E. R. (1991). Assay of aromatase activity. Methods Enzymol. 206, 477-483.
55. Liu, R., Hurtt, M. E., Cook, J. C., and Biegel, L. B. (1996). Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CD BR (CD) rats. Fundam. Appl. Toxicol. 30, 220-228.
56. Lyons, W. R., Berlin, I., and Friedlander, S. (1942). Cornification of balano-preputial epithelium in normal rats and in castrated rats treated with testosterone propionate. Endocrinology 31, 659-663.
57. MacDonald, M. C., and Wilkinson, M. (1990). Peripubertal treatment with N-methyl-D-aspartic acid or neonatally with monosodium glutamate accelerates sexual maturation in female rats, an effect reversed by MK-801. Neuroendocrinology 52, 143-149.
58. MacDonald, M. C., and Wilkinson, M. (1991). Occurence of sexual maturation in chronic opiate-treated female rats. J. Endocrinol. 129, 253-259.
59. Mak, P., DelaCruz, F., and Chen, S. (1999). A yeast screen system for aromatase inhibitors and ligands for androgen receptor: Yeast cells transformed with aromatase and androgen receptor. Environ. Health Perspect. 107, 855-860.
60. Mak, P., McDonnell, D. P., Weigel, N. L., Schrader, W. T., and O'Malley, B. W. (1989). Expression of functional chicken oviduct progesterone receptors in yeast (Saccharomyces cerevisiae). Journal of Biological Chemistry 265, 21613-21618.
61. Maric, D., Simonovic, I., Kovacevic, R., Krsmanovic, L., Stojilkovic, S., and Andjus, R. K. (1982). Effects of short-term and long-term hyperprolactinemia on the development pattern of androgen and LH levels in the immature male rat. J. Endocrinol. Invest. 1982, 235-241.
62. Marty, M. S., Crissman, J. W., and Carney, E. W. (1999). Evaluation of the EDSTAC female pubertal assay in CD rats using 17β-estradiol, steroid biosynthesis inhibitors, and a thyroid inhibitor. Toxicol. Sci. 52, 269-277.
63. Marty, M. S., Crissman, J. W., and Carney, E. W. (2001a). Evaluation of the male pubertal onset assay to detect testosterone and steroid biosynthesis inhibitors in CD rats. Toxicol. Sci. 60, 285-295.
64. Marty, M. S., Crissman, J. W., and Carney, E. W. (2001b). Evaluation of the male pubertal onset assay's ability to detect thyroid inhibitors and dopaminergic agents. Toxicol. Sci. 60, 63-76.
65. Marty, M. S., Johnson, K. A., and Carney, E. W. (2001c). Effect of feed restriction on Hershberger and pubertal male assay endpoints. The Toxicologist 60, 223 (abstract).
66. McDonnell, D. P., Nawaz, Z., Densmore, C., Weigel, N. L., Pham, T. A., Clark, J. H., and O'Malley, B. W. (1991). High level expression of biologically active estrogen receptor in Saccharomyces cerevisiae. J. Steroid Biochem. Mol. Biol. 39, 291-297.
67. McDonnell, D. P., Pike, J. W., Drutz, D. J., Butt, T. R., and O'Malley, B. W. (1989). Reconstruction of the vitamin D-responsive osteocalcin transcriptional unit in Saccharomyces cerevisiae. Mol. Cell Biol. 9, 3517-3523.
68. Metzger, D., White, J. H., and Chambon, P. (1988). The human estrogen receptor functions in yeast. Nature 334, 31-36.
69. Miyata, K., Yabushita, T., Sukata, T., Kunimatsu, T., Yamada, T., Sano, M., Yoshino, H., Nakanishi, T., Kamita, Y., Seki, T., and Okuno, Y. (2001). Effects of an antiandrogenic chemical, flutamide (FL), on male reproductive organs in a gestational and postnatal exposure study, in comparison with Hershberger and pubertal assays. The Toxicologist 60, 224.
70. Monosson, E., Kelce, W. R., Lambright, C., Ostby, J., and Gray, L. E. (1999). Peripubertal exposure to the antiandrogenic fungicide vinclozolin delays puberty, inhibits the development of androgen-dependent tissues and alters androgen receptor function in the male rat. Toxicol. Ind. Health 15, 65-79.
71. Morita, K., Ono, T., and Shimakawa, H. (1990). Inhibition of testosterone biosynthesis in testicular microsomes by various imidazole drags. Comparative study with ketoconazole. J. Pharmacobio-Dyn. 13, 336-343.
72. Nakagawa, Y., Enomoto, K., Nakano, K., and Yamashita, K. (1993). Microdetermination of estrogens by gas chromatography/selected ion recording. An application to the measurement of aromatase activity. Nippon Iyo Masu Supekutoru Gakkai Koenshu 18, 123-126.
73. Nazian, S. J. and Piacsek, B. E. (1977). Maturation of the reproductive system in male rats raised at a low ambient temperature. Biol. Reprod. 17, 668-675.
74. Nellemann, C., Vinggaard, A. M., Dalgaard, M., Hossaini, A., and Larsen, J. J. (2001). Quantification of antiandrogen effect determined by Lightcycler technology. Toxicology 163, 29-38.
75. Nilson, A., Obourn, J. D., Cook, J. C., Wicks, J. R., Snyder, P. A., Clemo, F. A., and Lawton, M. P. (2001). Detecting the thyroid toxicants phenobarbital (PB) and propylthiouracil (PTU) using traditional endocrine endpoints and gene expression. The Toxicologist 60, 1079 (abstract).
76. O'Connor, J. C., Cook, J. C., Craven, S. C., VanPelt, C. S., and Obourn, J. D. (1996). An in vivo battery for identifying endocrine modulators that are estrogenic or dopamine regulators. Fundam. Appl. Toxicol. 33, 182-195.
77. O'Connor, J. C., Cook, J. C., Slone, T. W., Makovec, G. T., Frame, S. R., and Davis, L. G. (1998a). An ongoing validation of a Tier I screening battery for detecting endocrine-active compounds (EACs). Toxicol. Sci. 46, 45-60.
78. O'Connor, J. C., Frame, S. R., Biegel, L. B., Cook, J. C., and Davis, L. G. (1998b). Sensitivity of a Tier I screening battery compared to an in utero exposure for detecting the estrogen receptor agonist 17β-estradiol. Toxicol. Sci. 44, 169-184.
79. O'Connor, J. C., Frame, S. R., Davis, L. G., and Cook, J. C. (1999a). Detection of the environmental antiandrogen p,p′-DDE in CD and Long-Evans rats using a Tier I screening battery and a Hershberger assay. Toxicol. Sci. 51, 44-53.
80. O'Connor, J. C., Frame, S. R., Davis, L. G., and Cook, J. C. (1999b). Detection of thyroid toxicants in a Tier I screening battery and alterations in thyroid endpoints over 28 days of exposure. Toxicol. Sci. 51, 54-70.
81. O'Connor, J. C., Frame, S. R., Davis, L. G., and Cook, J. C. (2000a). Detection of dopaminergic modulators in a Tier I screening battery for detecting endocrine-active compounds (EACs). Reprod. Toxicol. 14, 193-205.
82. O'Connor, J. C., Frame, S. R., Davis, L. G., and Cook, J. C. (2000b). Evaluation of a Tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486. Toxicol. Sci. 54, 338-354.
83. O'Connor, J. C., Frame, S. R., Smith, C., and Ladics, G. (2000c). Comparison of the oral (gavage) and intraperitoneal routes of administration for identifying endocrine-active compounds (EACs) using an in vivo male battery, and evaluation of immune system endpoints. Toxicol. Sci. Supplement - The Toxicologist 54, 261.
84. O'Connor, J. C., Plowchalk, D. R., VanPelt, C. S., Davis, L. G., and Cook, J. C. (2000d). Role of prolactin (PRL) in chloro-s-triazine-mediated rat mammary tumors. Drug. Chem. Toxicol. 23, 575-601.
85. Odum, J., Lefevre, P. A., Tittensor, S., Paton, D., Routledge, E. J., Beresford, N. A., Sumpter, J. P., and Ashby, J. (1997). The rodent uterotrophic assay: Critical protocol features, studies with nonyl phenols, and comparisons with a yeast estrogenicity assay. Reg. Toxicol. Pharmacol. 25, 176-188.
86. Odum, J., Tinwell, H., Jones, K., VanMiller, J. P., Joiner, R. L., Tobin, G., Kawasaki, H., and Ashby, J. (2001). Effect of rodent diets on the sexual development of the rat. Toxicol. Sci. 61, 115-127.
87. Ojeda, S. R. and Urbanski, H. F. (1994). Puberty in the rat. In: The Physiology of Reproduction (D. W. Pfaff, Ed., Vol. 2, pp. 363-409). Raven Press, New York.
88. O'Keefe, J. A. and Handa, R. J. (1990). Transient elevation of estrogen receptors in the neonatal rat hippocampus. Develop. Brain. Res. 57, 119-127.
89. Pham, T. A., Elliston, J. F., Nawaz, Z., McDonnell, D. P., Tsai, M. J., and O'Malley, B. W. (1991). Antiestrogen can establish nonproductive receptor complexes and alter chromatin structure at target enhancers. Proc. Natl. Acad. Sci. U.S.A. 88, 3125-3129.
90. Pham, T. A., Hwung, Y.-P., Santiso-Mere, D., McDonnell, D. P., and O'Malley, B. W. (1992). Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast. Mol. Endocrinol. 6, 1043-1050.
91. Powlin, S. S., Cook, J. C., Novak, S., and O'Connor, J. C. (1998). Ex vivo and in vitro testis and ovary explants: Utility for identifying steroid biosynthesis inhibitors and comparison to a Tier I screening battery. Toxicol. Sci. 46, 61-74.
92. Purba, H. S. and Bhatnagar, A. S. (1990). A comparison of methods measuring aromatase activity in human placenta and rat ovary. J. Enzyme Inhibition 4, 169-178.
93. Purvis, I. J., Chotai, D., Dykes, C. W., Lubahn, D. B., French, F. S., Wilson, E. M., and Hobden, A. N. (1991). An androgen-inducible expression system for Saccharomyces cerevisiae. Gene 106, 35-42.
94. Ramaley, J. A., and Phares, C. K. (1983). Delay of puberty onset in males due to supression of growth hormone. Neuroendocrinology 36, 321-329.
95. Raynaud, J. P., Bonne, C., Moguilewsky, M., Lefebvre, F. A., Belanger, A., and Labrie, F. (1984). The pure antiandrogen RU 23908 (Anandron), a candidate of choice for the combined antihormonal treatment of prostatic cancer: A review. Prostate 5, 299-311.
96. Reel, J. R., Lamb-IV, J. C., and Neal, B. H. (1996). Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fundam. Appl. Toxicol. 34, 288-305.
97. Ronnekleiv, O. K., Ojeda, S. R., and McCann, S. M. (1978). Undernutrition, puberty, and the development of estrogen positive feedback in the female rat. Biol. Reprod. 19, 414-424.
98. Routledge, E. J., and Sumpter, J. P. (1996). Estrogenic activity of surfactants and some of theirdegradation products assesses using a recombinant yeast screen. Environ. Toxicol. Chem. 15, 241-248.
99. Schena, M. and Yamamoto, K. R. (1988). Mammalian glucocorticoid receptor derivatives enhance transcription in yeast. Science 241, 965-967.
100. Shelby, M. D., Newbold, R. R., Tully, D. B., Chae, K., and Davis, V. L. (1996). Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ. Health Perspect. 104, 1296-1300.
101. Sigle, R. O., Titus, M. A., Harada, N., and Nelson, S. D. (1994). Baculovirus mediated high level expression of human placental aromatase (CYP19A1). Biochem. Biophys. Res. Commun. 201, 694-700.
102. Smith, S. S., Neuringer, M., and Ojeda, S. R. (1989). Essential fatty acid deficiency delays the onset of puberty in the female rat. Endocrinology 125, 1650-1659.
103. Srinivasan, G. (1992). Overexpression of receptors of the steroid/thyroid family. Mol. Endocrinol. 6, 857-860.
104. Stoker, T. E., Laws, S. C., Guidici, D. L., and Cooper, R. L. (2000a). The effect of atrazine on puberty in male wistar rats: An evaluation in the protocol for assessment of pubertal development and thyroid function. Toxicol. Sci. 58, 50-59.
105. Stoker, T. E., Parks, L. G., Gray, L. E., and Cooper, R. L. (2000b). Endocrine-disrupting chemicals: Prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Crit. Rev. Toxicol. 30, 197-252.
106. Thyssen, S. M. and Libertun, C. (1996). Alphadifluoromethylornithine modifies FSH secretion and puberty onset in the female rat. Proc. Soc. Exp. Biol. Med. 211, 76-80.
107. Traish, A. M., Muller, R. E., and Wotiz, H. H. (1986). Bindng of 7α, 17α-dimethyl-19-nortestosterone to androgen and progesterone receptors in human and animal tissues. Endocrinology 118, 1327-1333.
108. Trkulja, V. and Lackovic, Z. (1996). Involvement of muscarinic receptors in the control of female puberty in the rat. Eur. J. Pharmacol. 297, 93-96.
109. Valle, L. B., Oliveira-Filho, R. M., Romaldini, J. H., and Lara, P. F. (1985). Pituitary-testicular axis abnormalities in immature male hypothyroid rats. J. Steroid Biochem. 23, 253-257.
110. Varsho, B. J., Stump, D. G., Becker, R. A., and Owens, J. W. (2001). OECD rodent uterotrophic assay validation variables: Blinded administration, animal model, and route of administration. The Toxicologist 60, 295 (abstract).
111. Veneroni, O., Cocilovo, L., Muller, E., and Cocchi, D. (1990). Delay of puberty and impairment of growth in female rats given a non-competitive antagonist of NMDA receptors. Life Sci. 47, 1253-1260.
112. Vigersky, R. A., Mozingo, D., Eil, C., Vishnudutt, P., and Bruton, J. (1982). The antiandrogenic effects of 1-testolactone (Teslac) in vivo in rats and in vitro in human cultured fibroblasts, rat mammary carcinoma cells, and rat prostate cytosol. Clin. Invest. Serv. 110, 214-219.
113. Viguier-Martinez, M. C., Hochereau-de-Reviers, M. T., Barenton, B., and Perreau, C. (1983a). Effect of a non-steroidal antiandrogen, flutamide, on the hypothalamo-pituitary axis, genital tract and testis in immature rats: Endocrinological and histological data. Acta Endocrinol. 102, 299-306.
114. Viguier-Martinez, M. C., Hochereau-de-Reviers, M. T., Barenton, B., and Perreau, C. (1983b). Endocrinological and histological changes induced by flutamide treatment on the hypothalamo-hypophyseal testicular axis of the adult male rat and their incidences on fertility. Acta Endocrinol. 104, 246-252.
115. Vinggaard, A. M., Hnida, C., Breinholt, V., and Larsen, J. C. (2000). Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro. Toxicol. In Vitro 14, 227-234.
116. Wagner, B. L., Pollio, G., Leonhardt, S., Wani, M. C., Lee, D. Y.-W., Imhof, M. O., Edwards, D. P., Crook, C. E., and McDonnell, D. P. (1996). 16α-Substituted analogs of the antiprogestin RU486 induce a unique conformation in the progesterone receptor resulting in mixed agonist activity. Proc. Natl. Acad. Sci. U.S.A. 93, 8739-8744.
117. Wakeling, A. E., Furr, B. J., Glen, A. T., and Hughes, L. R. (1981). Receptor binding and biological activity of steroidal and nonsteroidal antiandrogens. J. Steroid Biochem. 15, 355-359.
118. Whitten, P. L. and Naftolin, F. (1992). Effects of a phytoestrogen diet on estrogen-dependent reproductive processes in immature female rats. Steroids 57, 56-61.
119. Widdowson, E. M. and McCance, R. A. (1960). Some effects of accelerating growth. I. General somatic development. Proc. Roy. Soc. B 152, 188-206.
120. Wilson, V. S., Bobseine, K., Lambright, C., and Gray, L. E. (2000). Standardization and validation of a novel cell line that stably expresses the luciferase reporter for the detection of androgen receptor (AR) agonists and antagonists. Biol. Reprod. 62 (Suppl. 1), 243.
121. Wooge, C. H., Nilsson, G. M., Heierson, A., McDonnell, D. P., and Katzenellenbogen, B. S. (1992). Structural requirements for high affinity ligand binding by estrogen receptors: A comparative analysis of truncated and full-length estrogen receptors expressed in bacteria, yeast, and mammalian cells. Mol. Endocrinol. 6, 861-869.
122. Yamada, T., Kunimatsu, T., Sako, H., Yabushita, S., Sukata, T., Okuno, Y., and Matsuo, M. (2000). Comparative evaluation of a 5-day Hershberger assay utilizing mature male rats and a pubertal male assay for detection of flutamide's antiandrogenic activity. Toxicol. Sci. 53, 289-296.
123. Yamada, T., Sunami, O., Kunimatsu, T., Kamita, Y., Okuno, Y., Seki, T., Nakatsuka, I., and Matsuo, M. (2001). Dissection and weighing of accessory sex glands after formalin fixation, and a 5-day assay using young mature rats are reliable and feasible in the Hershberger assay. Toxicology 162, 103-119.
124. Yamasaki, K., Sawaki, M., Noda, S., and Takatsuki, M. (2001a). Effects of age and weaning on the immature rat uterotrophic assay using ethynylestradiol. Exp. Anim. 50, 87-89.
125. Yamasaki, K., Sawaki, M., Noda, S., and Takatsuki, M. (2001b). Strain sensitivity differences in the Hershberger assay. Reprod. Toxicol. 15, 437-440.
126. 3H]methyltrienolone in the presence and absence of progesterone receptors. Endocrinology 104, 1007-1012.
127. Zipf, W. B., Payne, S. H., and Kelch, R. P. (1978). Prolactin, growth hormone, and luteinizing hormone in the maintenance of testicular luteinizing hormone receptors. Endocrinology 103, 595-600.
128. Zysk, J. R., Johnson, B., Ozenberger, B. A., Bungham, B., and Gorski, J. (1995). Selective uptake of estrogenic compounds in Saccharomyces cerevisiae: A mechanism for antiestrogen resistance in yeast expressing the mammalian estrogen receptor. Endocrinology 136, 1323-1326.